Micro-fractures in the constitutive elements of the vertebrae mainly caused by bone thinning are called vertebral compression fractures (VCF). Vertebral compression fracture occurs due to the compression of a single bone due to trauma. The surgical approach for VCF treatment includes the injection of bone cement through a small hole in the fractured vertebra to provide immediate pain relief and stabilization for the patient.
The cementing material provides a scaffold for the back bone for additional support. Cortical thinning, reduced bone mineral density and osteoporosis are the main factors that cause vertebral compression fractures. Postmenopausal women are more prone to vertebral fractures. The ultimate goal of vertebral compression fracture devices is to eliminate back pain, melt and repair fractures, restore posture and provide ease of movement.
Download the PDF Bbrochure: https://www.coherentmarketinsights.com/insight/request-pdf/802
Kyphoplasty and vertebroplasty are the advanced techniques of osteoporotic compression. Kyphoplasty is performed on patients with severe pain even after weeks of non-surgical or drug-related treatment. The technique involves the expansion for the formation of cavities and the injection of cement which can be performed with less pressure. Vertebroplasty is generally not recommended by the American Academy of Orthopedic Surgeons (AAOS), due to increased rates of extravasation and complications without beneficial effects.
The increase in the prevalence of osteoporosis drives the market for vertebral compression fracture devices
According to estimates by the International Osteoporosis Foundation in 2010, osteoporosis globally affects 200 million people with about 9 million new osteoporotic fractures, with 1.6 million hip fractures, 1.7 million hip fractures. Forearm and 1.4 million clinical vertebral fractures. The increasing incidence of arthritis and osteoporosis, the inability of medicinal therapy to treat vertebral compression fracture at an optimal level and the advent of minimally invasive spinal surgeries guide the market growth of vertebral compression fracture devices . Furthermore, a short recovery period, a low risk of infection, a limited hospital stay and an increase in the geriatric population are expected to increase the demand for VCF devices globally. However, the rigorous regulatory approval process and the risk of post-surgical complications such as neurological lesions and impaired lung function should curb market growth.
Asia-Pacific is expected to grow rapidly with the increase in health care costs to meet unmet medical needs
The regional segmentation of the global VCF market of Coherent Market Insights includes North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. According to estimates by the World Health Organization in 2015, vertebral compression fractures (VCF) are the common type of fragility fractures with 700,000 cases of VCF per year in the United States, with 30% of women postmenopausal that could experience fractures of the humerus, hip and spine pushing the demand for innovative VCF devices.
Main players operating in the global market of vertebral compression fracture devices includes Alphatec Holdings, Inc., Depuy Synthes, Osseon LLC, VEXIM SA and Orthovita, Inc. The launch of the innovative CurvePlus device and InterV line offers atraumatic treatment that allows pain management clinics to have a more routine safe and faster. Other major suppliers are Stryker Corporation, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., DFine, Inc. and CareFusion Corporation.
Click to learn more about the vertebral compression fracture device market